Discover
IMCR
Immunocore Holdings plc
34.18
1 x 33.16
1 x 35.32
bid
ask
+
0.20
0.59%
undefined @ 04:00 PM
34.18 +0.00 (0.00%)
| Ytd | -1.53% | |
| 1y | 7.18% |
33.62
day range
34.62
27.55
52 week range
40.72
| Open | 33.77 | Prev Close | 33.98 | Low | 33.62 | High | 34.62 | Mkt Cap | 1.74B |
| Vol | 0.00 | Avg Vol | 530.27K | EPS | -0.35 | P/E | -96.44 | Forward P/E | -44.65 |
| Beta | 0.74 | Short Ratio | 12.69 | Inst. Own | 101.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 31.68 | 200-d Avg | 32.51 | 1yr Est | 63.63 |
| Income Statement | |||
| Total Revenue | 115.93M | ||
| Revenues (USD) | 115.93M | ||
| Cost of Revenue | 1.09M | ||
| Gross Profit | 114.84M | ||
| Operating Expenses | 117.84M | ||
| Research and Development Expense | 73.94M | ||
| Selling, General and Administrative Expense | 43.89M | ||
| Operating Income | -3.00M | ||
| Interest Expense | 3.06M | ||
| Income Tax Expense | 294.00K | ||
| Net Income | -808.00K | ||
| Net Income Common Stock | -808.00K | ||
| Net Income Common Stock (USD) | -808.00K | ||
| Consolidated Income | -808.00K | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 2.55M | ||
| Earning Before Interest & Taxes (USD) | 2.55M | ||
| Weighted Average Shares | 50.97M | ||
| Weighted Average Shares Diluted | 50.97M | ||
| Balance Sheet | |||
| Cash and Equivalents | 484.92M | ||
| Cash and Equivalents (USD) | 484.92M | ||
| Investments | 395.29M | ||
| Investments Current | 395.29M | ||
| Trade and Non-Trade Receivables | 95.35M | ||
| Current Assets | 1.05B | ||
| Property, Plant & Equipment Net | 49.88M | ||
| Total Assets | 1.12B | ||
| Debt Current | 1.91M | ||
| Total Debt | 434.96M | ||
| Current Liabilities | 235.20M | ||
| Debt Non-Current | 433.05M | ||
| Total Liabilities | 699.62M | ||
| Accumulated Retained Earnings (Deficit) | -819.11M | ||
| Accumulated Other Comprehensive Income | -34.33M | ||
| Shareholders Equity | 419.80M | ||
| Shareholders Equity (USD) | 419.80M | ||
| Assets Non-Current | 68.38M | ||
| Total Debt (USD) | 434.96M | ||
| Deferred Revenue | 5.06M | ||
| Inventory | 7.79M | ||
| Liabilities Non-Current | 464.43M | ||
| Trade and Non-Trade Payables | 26.32M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.64M | ||
| Net Cash Flow from Financing | 16.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 31.63M | ||
| Capital Expenditure | -786.00K | ||
| Issuance (Purchase) of Equity Shares | 16.49M | ||
| Net Cash Flow from Investing | -786.00K | ||
| Net Cash Flow from Operations | 15.93M | ||
| Share Based Compensation | 9.40M | ||